pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 4·1 min read
save

Supreme Court reverses stay, allowing mail ordering of abortion pill mifepristone

May 4, 2026·read at Endpoints ↗RegulatoryPositive

The U.S. Supreme Court issued a decision on Monday that restores the ability to order the abortion medication mifepristone by mail. This action overturns a stay that had been placed by a federal appeals court.

The ruling came after the manufacturers of the drug requested an immediate response to the appellate court's order. By lifting the stay, the Court enables patients to obtain the medication through postal delivery once again.

The decision is expected to affect access to the pill across the country, reinstating the distribution method that had been in place before the appellate court's intervention.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Supreme Court restores mifepristone access by mail”

read at Endpoints ↗
75 words · retrieved May 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Sionna Therapeutics, Inc.
drugs
MIFEPRISTONE3

related stories

  • May 8The aging scientific workforce collides with rising fabricating citations in medical journalsSTAT
  • May 8Natalie Holles' next move after Third Harmonic shutdown; Mark Alles passes the torch at ADC biotechEndpoints
  • May 7Amazon adds Ozempic pill to same-day prescription drug kiosksEndpoints
  • May 7Hospital shootings steadily increased since 2000STAT
  • May 6Lonza looks to ride ADC wave with upcoming factory, workforce expansionEndpoints